Field & Main Bank bought a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) during the 2nd quarter, Holdings Channel reports. The institutional investor bought 3,856 shares of the medical equipment provider’s stock, valued at approximately $1,533,000.
Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. State Street Corp increased its holdings in shares of Intuitive Surgical by 1.0% during the fourth quarter. State Street Corp now owns 15,701,591 shares of the medical equipment provider’s stock valued at $8,892,753,000 after acquiring an additional 162,264 shares in the last quarter. Capital World Investors boosted its stake in Intuitive Surgical by 1.7% in the 4th quarter. Capital World Investors now owns 7,856,018 shares of the medical equipment provider’s stock worth $4,449,491,000 after purchasing an additional 127,526 shares in the last quarter. Norges Bank purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $2,856,987,000. Invesco Ltd. grew its position in Intuitive Surgical by 17.4% during the 4th quarter. Invesco Ltd. now owns 4,128,735 shares of the medical equipment provider’s stock worth $2,338,350,000 after purchasing an additional 611,268 shares during the last quarter. Finally, Bank of America Corp DE increased its stake in Intuitive Surgical by 3.3% during the 1st quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock valued at $1,667,388,000 after purchasing an additional 116,292 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.
Intuitive Surgical Price Performance
ISRG stock opened at $372.60 on Friday. The firm’s fifty day simple moving average is $384.60 and its 200-day simple moving average is $432.76. The company has a market capitalization of $131.63 billion, a P/E ratio of 42.68, a price-to-earnings-growth ratio of 2.65 and a beta of 1.46. Intuitive Surgical, Inc. has a 12 month low of $328.57 and a 12 month high of $603.88.
Insider Buying and Selling
In other Intuitive Surgical news, EVP Mark Brosius sold 77 shares of the stock in a transaction dated Friday, August 21st. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89. Following the sale, the executive vice president directly owned 881 shares of the company’s stock, valued at approximately $330,877.17. This trade represents a 8.04% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of Intuitive Surgical stock in a transaction dated Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the transaction, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 17,283 shares of company stock valued at $7,015,429 in the last 90 days. 0.60% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
ISRG has been the subject of a number of research analyst reports. UBS Group initiated coverage on shares of Intuitive Surgical in a report on Tuesday, July 28th. They issued a “neutral” rating and a $500.00 price target for the company. BMO Capital Markets reissued an “outperform” rating on shares of Intuitive Surgical in a research report on Monday, July 20th. Truist Financial reduced their target price on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating for the company in a research note on Thursday, July 16th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Friday, August 14th. Finally, KeyCorp reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Twenty-two equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $508.68.
Read Our Latest Analysis on ISRG
About Intuitive Surgical
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Further Reading
- Five stocks we like better than Intuitive Surgical
- 3 Financial Stocks Positioned for the Fed’s Next Move After Jackson Hole
- IREN’s AI Pivot Looks Real, But the Market Wanted a Faster Payoff After Earnings
- Boeing’s $131B F-15 Win: Mach 1 Momentum or Just Altitude?
- Okta Stock Surges 29%—Is $200 the Next Stop?
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.
